Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $281
Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $231 to $281.
Read original at benzingaStocks · News reference
Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $270 to $290.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $231 to $281.
Read original at benzingaRSI warning: 3 overbought health care stocks could be flashing a real warning to investors with high momentum trading preferences
Read original at benzinga